NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D. as chief strategy officer of the organization, effective immediately.
“The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team at Catalyst OrthoScience”
“I am grateful and excited to embrace this opportunity with the Catalyst team and to return to my professional roots in shoulder orthopedics,” said Ables. “I look forward to contributing with vigor and vision, steering our efforts toward growth and excellence with strategies that are both responsive to the present and attune to the necessary investments for our future success.”
Ables brings nearly 20 years of medical device experience to Catalyst, including more than a decade in upper extremity orthopedics. She has held leadership roles in sales, marketing, medical education and sales training at Tornier and Wright Medical before departing for ATEC spine.
Most recently, Ables served as the vice president of Customer Engagement and Sales Excellence at Cutera, a medical aesthetics organization. Prior to Cutera and through the peak of the COVID-19 pandemic, Ables was the chief learning officer at Vyaire Medical, a global organization focused on respiratory care.
Throughout her career, Ables built a reputation as a strong leader focused on the customer, with an incomparable energy for continuous learning, strategy development and execution. Ables is a highly skilled, relatable leader driven to deliver results through team achievement. She is a culture carrier who believes credibility is critical, and always leads by example.
Ables received a Bachelor of Science in Sports Medicine from the University of Charleston, a master’s in Biomechanics and a Ph.D. in Human Performance from Texas Woman’s University in 2003.
About Catalyst OrthoScience Inc.
Naples, Florida-based Catalyst OrthoScience was founded in 2014 by orthopedic surgeon Steven Goldberg, MD, who saw the need to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery. Catalyst is disrupting the traditional approach to shoulder replacement surgery. Our total shoulder systems offer precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. Catalyst has a growing portfolio of patents and pending patents on its distinctive offerings, which are available across the U.S. For more information, visit www.catalystortho.com.
Contacts
Nancy McCarroll, CAO
570.335.7417
nmccarroll@catalystortho.com
